Charlotte 24fe Kit
Product Images NDC 68462-852

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Charlotte 24fe (NDC 68462-852). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Glenmark Pharmaceuticals Inc., Usa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure-1 (Figure 1)

A pharmacokinetic curve showing norethindrone concentration (pg/mL) on the vertical axis versus time (hours) on the horizontal axis. Data points with error bars illustrate concentrations decreasing over 36 hours.*

FDA Label Image

Figure-2 (Figure 2)

A line graph showing ethynyl estradiol concentration (pg/mL) over time (hours). The graph illustrates concentration rising sharply to around 80 pg/mL early, then gradually decreasing over 36 hours with error bars at each data point.*

FDA Label Image

Figure-3 (Figure 3)

A vertical arrow chart showing pregnancy rates per 100 women in one year, organized by type of birth control method. At the top (fewer pregnancies) are implants, injections, intrauterine devices, and sterilization; below them are birth control pills, skin patch, and vaginal ring with hormones; further down are condoms and diaphragm; then no sex during fertile days, spermicide, and withdrawal; finally, no birth control at the bottom (more pregnancies).*

FDA Label Image

Figure-4 (Figure 4)

An illustrated weekly pill chart diagram for Charlotte 24Fe, showing a 4-week cycle with circles representing each day's pill to be taken from left to right. Days of the week (Sunday to Saturday) are labeled horizontally, with weekly rows labeled vertically (Week 1 to Week 4). Directions for Sunday and Day-1 starters are indicated at the top, along with full drug name: norethindrone acetate and ethinyl estradiol tablets, USP and ferrous fumarate tablets, USP 1 mg/20 mcg.*

FDA Label Image

Image 01

A forest plot chart illustrating relevant studies on the risk of breast cancer associated with combined oral contraceptives (COC). It compares ever COC use versus never use and current COC use versus never use, showing effect estimates such as odds ratios (OR), relative risks (RR), and hazard ratios (HR) with confidence intervals plotted along an axis ranging approximately from -1.50 to 2.00.*

FDA Label Image

Laminate (Laminate)

Charlotte 24 Fe Kit containing norethindrone acetate and ethinyl estradiol and ferrous fumarate tablets, USP 1 mg/20 mcg, white mint-flavored tablets. The label indicates 1 blister pack of 28 tablets, manufactured by Glenmark Pharmaceuticals Inc., USA. The packaging includes dosage and storage information along with manufacturer details and a barcode.*

FDA Label Image

Logo-1 (Logo 1)

FDA Label Image

Logo-2 (Logo 2)

FDA Label Image

Structure-1 (Structure 1)

Chemical structure of the active ingredient norethindrone acetate and ethinyl estradiol in Charlotte 24Fe, a human prescription drug kit by Glenmark Pharmaceuticals Inc., USA. The image depicts the molecular arrangement characteristic of ethinyl estradiol.*

FDA Label Image

Structure-2 (Structure 2)

Chemical structure of norethindrone acetate, a component of Charlotte 24Fe oral contraceptive kit by Glenmark Pharmaceuticals Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.